Variants in the PNPLA3 gene, especially the I148M polymorphism, have been implicated in increased susceptibility to liver disease and MASLD in particular [5,16,17,18,19]. Here, PNPLA3 is linked to metabolic dysfunction-associated steatotic liver disease.